Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-009054
Filing Date
2023-03-22
Accepted
2023-03-22 08:49:21
Documents
5
Effectiveness Date
2023-03-22

Document Format Files

Seq Description Document Type Size
1 S-8 inzy_s-8_2023_-_evergree.htm S-8 159411
2 EX-5.1 inzy-ex5_1.htm EX-5 19810
3 EX-23.2 inzy-ex23_2.htm EX-23 4622
4 EX-99.3 inzy-ex99_3.htm EX-99 125715
5 EX-FILING FEES inzy-exfiling_fees.htm EX-FILING FEES 32692
  Complete submission text file 0000950170-23-009054.txt   343345
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

EIN.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270733 | Film No.: 23751542
SIC: 2834 Pharmaceutical Preparations